Swiss Oncology and Cancer Immunology Breakthrough Platform (SOCIBP) for Precision Oncology
Prof. Rubin leads an SPHN-PHRT program with co-leads Holger Moch (UHZ), George Coukos (CHUV/UNIL), and Gunnar Rätsch (ETHZ), in collaboration with Olivier Elemento (Englander Institute for Precision Medicine). This Swiss Federal Government-funded project addresses a critical scientific gap in immuno-oncology, while simultaneously developing important molecular oncology tools. Despite the rapid acceleration of novel targeted and immunology-based therapies for cancer, tumor cell resistance remains one of the greatest unmet challenges. SOCIBP will both provide important new tools for the Swiss and international research community, and give insight into the mechanism of resistance for immuno-oncology.